Dravet Syndrome
Friday 10th Feb
I want to help create awareness for epilepsy as in our home our warrior carries his condition known as Dravet Syndrome.
Dravet syndrome, previously known as Severe Myoclonic Epilepsy of Infancy (SMEI), is a rare form of intractable epilepsy that begins in infancy and proceeds with accumulating morbidity that significantly impacts individuals throughout their lifetime. Dravet syndrome has an estimated incidence rate of 1:15,700 individuals, over 80% of whom have a mutation in their SCN1A gene [1].
Dravet syndrome is a Developmental and Epileptic Encephalopathy, or DEE, part of a group of severe epilepsies with frequent and difficult to treat seizures and significant developmental delays. Seizures in Dravet syndrome usually begin during the first 2-15 months of life, often in the presence of fever or warm temperatures. Seizures are frequently prolonged, and are not well managed with current medications. Patients present with a variety of seizure types that generally evolve with age. As with all DEEs, Dravet syndrome includes more than just difficult to control seizures. Other comorbidities such as developmental delay and abnormal EEGs often emerge during the second or third year of life. Common issues associated with Dravet syndrome include:
Prolonged seizures
Frequent seizures
Behavioral and developmental delays
Movement and balance issues
Orthopedic conditions
Delayed language and speech issues
Growth and nutrition issues
Sleeping difficulties
Chronic infections
Sensory integration disorders
Dysautonomia, or disruptions of the autonomic nervous system which can lead to difficulty regulating body temperature, heart rate, blood pressure, and other issues
Current treatment options are limited, and the constant care required for someone suffering from Dravet syndrome can severely impact the patient’s and the family’s quality of life. Patients with Dravet syndrome face a 15-20% mortality rate due to SUDEP (Sudden Unexpected Death in Epilepsy), prolonged seizures, seizure-related accidents such as drowning, and infections [2,3]. Research for improved treatments, particularly disease-modifying treatments, offers patients and families hope for a better quality of life for their loved ones.